Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | AGXT | P21549 | 3/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 7/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23701742 | 0.90 | CA1 (0.51) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL15499923 | 0.82 | CA1 (0.56) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL29999299 | 0.82 | CA1 (0.56) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL23701728 | 0.80 | CA1 (0.53) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10268377 | 0.77 | CA1 (0.50) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL16683577 | 0.77 | CA1 (0.50) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL8236696 | 0.77 | CA1 (0.61) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL30131192 | 0.77 | CA1 (0.61) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL23701857 | 0.76 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL23701854 | 0.76 | CA1 (0.53) | CA1CA2PDE3APDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4100413-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | AgroFresh Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| WO-2021158595-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | AGROFRESH INC. (US) | 2021-08-12 | — | — | WO | disclosed |
| US-20210238201-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | ALTER DOMUS US LLC | 2021-08-05 | — | — | US | disclosed |
| US-20210238201-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | ALTER DOMUS US LLC | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238201-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | OXA1L, BROX, CAT | CA1 4388/4885CA2 2915/4885PDE3A 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.